Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.78
(0.0%)
HKD 5.78
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 496.51 Million CNY | 20.79% |
| 2022 | 411.06 Million CNY | 17.94% |
| 2021 | 348.54 Million CNY | 7.29% |
| 2020 | 324.85 Million CNY | 8.3% |
| 2019 | 299.96 Million CNY | 19.59% |
| 2018 | 250.83 Million CNY | 19.68% |
| 2017 | 209.59 Million CNY | 71.42% |
| 2016 | 122.27 Million CNY | 47.2% |
| 2015 | 83.06 Million CNY | 63.75% |
| 2014 | 50.72 Million CNY | 38.05% |
| 2013 | 36.74 Million CNY | 55.28% |
| 2012 | 23.66 Million CNY | -68.87% |
| 2011 | 76.02 Million CNY | -21.83% |
| 2010 | 97.25 Million CNY | -4.88% |
| 2009 | 102.24 Million CNY | 201.02% |
| 2008 | 33.96 Million CNY | 3.8% |
| 2007 | 32.72 Million CNY | 44.12% |
| 2006 | 22.7 Million CNY | 319.24% |
| 2005 | 5.41 Million CNY | 109.74% |
| 2004 | -55.6 Million CNY | -232.16% |
| 2003 | 42.07 Million CNY | -38.81% |
| 2002 | 68.76 Million CNY | -15.0% |
| 2001 | 80.89 Million CNY | 17.04% |
| 2000 | 69.11 Million CNY | 8.66% |
| 1999 | 63.6 Million CNY | 20.51% |
| 1998 | 52.78 Million CNY | -37.51% |
| 1997 | 84.46 Million CNY | -4.44% |
| 1996 | 88.38 Million CNY | 139.84% |
| 1995 | 36.85 Million CNY | -33.76% |
| 1994 | 55.63 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 78.67 Million CNY | -36.31% |
| 2024 Q1 | 141.87 Million CNY | 35.71% |
| 2024 Q2 | 123.52 Million CNY | -12.94% |
| 2023 Q4 | 104.54 Million CNY | -14.42% |
| 2023 Q2 | 118.2 Million CNY | -22.03% |
| 2023 FY | 496.51 Million CNY | 20.79% |
| 2023 Q3 | 122.16 Million CNY | 3.35% |
| 2023 Q1 | 151.6 Million CNY | 28.75% |
| 2022 Q1 | 108.5 Million CNY | 71.65% |
| 2022 Q4 | 117.75 Million CNY | 18.88% |
| 2022 Q3 | 99.05 Million CNY | 15.33% |
| 2022 FY | 411.06 Million CNY | 17.94% |
| 2022 Q2 | 85.88 Million CNY | -20.84% |
| 2021 Q3 | 85.25 Million CNY | -14.58% |
| 2021 Q1 | 100.27 Million CNY | 27.26% |
| 2021 Q2 | 99.8 Million CNY | -0.47% |
| 2021 Q4 | 63.21 Million CNY | -25.85% |
| 2021 FY | 348.54 Million CNY | 7.29% |
| 2020 Q4 | 78.79 Million CNY | 6.83% |
| 2020 Q1 | 86.28 Million CNY | 40.61% |
| 2020 FY | 324.85 Million CNY | 8.3% |
| 2020 Q3 | 73.75 Million CNY | -14.26% |
| 2020 Q2 | 86.02 Million CNY | -0.3% |
| 2019 Q2 | 72.02 Million CNY | -4.53% |
| 2019 FY | 299.96 Million CNY | 19.59% |
| 2019 Q1 | 75.44 Million CNY | 31.2% |
| 2019 Q3 | 91.12 Million CNY | 26.51% |
| 2019 Q4 | 61.36 Million CNY | -32.66% |
| 2018 Q2 | 55.77 Million CNY | -17.49% |
| 2018 Q3 | 69.96 Million CNY | 25.46% |
| 2018 FY | 250.83 Million CNY | 19.68% |
| 2018 Q1 | 67.59 Million CNY | 88.19% |
| 2018 Q4 | 57.5 Million CNY | -17.82% |
| 2017 Q3 | 66.89 Million CNY | 21.14% |
| 2017 Q1 | 51.55 Million CNY | 55.78% |
| 2017 Q2 | 55.22 Million CNY | 7.13% |
| 2017 FY | 209.59 Million CNY | 71.42% |
| 2017 Q4 | 35.91 Million CNY | -46.31% |
| 2016 FY | 122.27 Million CNY | 47.2% |
| 2016 Q3 | 43.31 Million CNY | 69.39% |
| 2016 Q2 | 25.57 Million CNY | 25.98% |
| 2016 Q1 | 20.29 Million CNY | -4.63% |
| 2016 Q4 | 33.09 Million CNY | -23.6% |
| 2015 FY | 83.06 Million CNY | 63.75% |
| 2015 Q1 | 14.25 Million CNY | 443.67% |
| 2015 Q4 | 21.28 Million CNY | -40.75% |
| 2015 Q3 | 35.92 Million CNY | 209.65% |
| 2015 Q2 | 11.6 Million CNY | -18.65% |
| 2014 Q3 | 8.11 Million CNY | -77.94% |
| 2014 Q4 | 2.62 Million CNY | -67.68% |
| 2014 FY | 50.72 Million CNY | 38.05% |
| 2014 Q1 | 3.19 Million CNY | 111.3% |
| 2014 Q2 | 36.79 Million CNY | 1051.23% |
| 2013 Q1 | -8.11 Million CNY | 4.04% |
| 2013 Q3 | 30.24 Million CNY | 130.77% |
| 2013 FY | 36.74 Million CNY | 55.28% |
| 2013 Q4 | 1.51 Million CNY | -95.0% |
| 2013 Q2 | 13.1 Million CNY | 261.44% |
| 2012 Q3 | 928.59 Thousand CNY | -94.34% |
| 2012 Q2 | 16.4 Million CNY | 10.98% |
| 2012 FY | 23.66 Million CNY | -68.87% |
| 2012 Q1 | 14.78 Million CNY | 470.7% |
| 2012 Q4 | -8.46 Million CNY | -1011.07% |
| 2011 Q4 | -3.98 Million CNY | -120.66% |
| 2011 Q1 | 28.94 Million CNY | 283.01% |
| 2011 Q2 | 31.75 Million CNY | 9.73% |
| 2011 Q3 | 19.31 Million CNY | -39.2% |
| 2011 FY | 76.02 Million CNY | -21.83% |
| 2010 Q3 | 31.81 Million CNY | 6.5% |
| 2010 FY | 97.25 Million CNY | -4.88% |
| 2010 Q1 | 28 Million CNY | -28.33% |
| 2010 Q2 | 29.87 Million CNY | 6.67% |
| 2010 Q4 | 7.55 Million CNY | -76.25% |
| 2009 Q3 | 23.28 Million CNY | 7.3% |
| 2009 Q2 | 21.69 Million CNY | 19.27% |
| 2009 FY | 102.24 Million CNY | 201.02% |
| 2009 Q1 | 18.19 Million CNY | 115.99% |
| 2009 Q4 | 39.07 Million CNY | 67.85% |
| 2008 FY | 33.96 Million CNY | 3.8% |
| 2008 Q4 | 8.42 Million CNY | 65.58% |
| 2008 Q3 | 5.08 Million CNY | -35.68% |
| 2008 Q2 | 7.9 Million CNY | -36.99% |
| 2008 Q1 | 12.54 Million CNY | 51.59% |
| 2007 Q2 | 9.12 Million CNY | -6.19% |
| 2007 Q1 | 9.72 Million CNY | 53.95% |
| 2007 FY | 32.72 Million CNY | 44.12% |
| 2007 Q4 | 8.27 Million CNY | 47.86% |
| 2007 Q3 | 5.59 Million CNY | -38.63% |
| 2006 Q4 | 6.31 Million CNY | 56.84% |
| 2006 Q3 | 4.02 Million CNY | 52.85% |
| 2006 Q2 | 2.63 Million CNY | -72.91% |
| 2006 FY | 22.7 Million CNY | 319.24% |
| 2006 Q1 | 9.72 Million CNY | 171.93% |
| 2005 Q2 | 6.67 Million CNY | -25.45% |
| 2005 Q4 | -13.52 Million CNY | -507.63% |
| 2005 Q3 | 3.31 Million CNY | -50.28% |
| 2005 FY | 5.41 Million CNY | 109.74% |
| 2005 Q1 | 8.94 Million CNY | 110.39% |
| 2004 Q3 | 3.2 Million CNY | -67.05% |
| 2004 Q1 | 17.59 Million CNY | 333.11% |
| 2004 FY | -55.6 Million CNY | -232.16% |
| 2004 Q2 | 9.72 Million CNY | -44.72% |
| 2004 Q4 | -86.14 Million CNY | -2786.8% |
| 2003 FY | 42.07 Million CNY | -38.81% |
| 2003 Q3 | 6.27 Million CNY | -67.88% |
| 2003 Q2 | 19.53 Million CNY | -18.0% |
| 2003 Q1 | 23.82 Million CNY | 102.08% |
| 2003 Q4 | -7.54 Million CNY | -220.35% |
| 2002 Q2 | 17.37 Million CNY | -26.38% |
| 2002 Q1 | 23.6 Million CNY | 0.0% |
| 2002 Q3 | 15.98 Million CNY | -7.99% |
| 2002 Q4 | 11.78 Million CNY | -26.28% |
| 2002 FY | 68.76 Million CNY | -15.0% |
| 2001 FY | 80.89 Million CNY | 17.04% |
| 2000 FY | 69.11 Million CNY | 8.66% |
| 1999 FY | 63.6 Million CNY | 20.51% |
| 1998 FY | 52.78 Million CNY | -37.51% |
| 1997 FY | 84.46 Million CNY | -4.44% |
| 1996 FY | 88.38 Million CNY | 139.84% |
| 1995 FY | 36.85 Million CNY | -33.76% |
| 1994 FY | 55.63 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 105.03 Million HKD | -372.693% |
| Grand Pharmaceutical Group Limited | 1.87 Billion HKD | 73.59% |
| Extrawell Pharmaceutical Holdings Limited | -162.94 Million HKD | 404.704% |
| Wai Yuen Tong Medicine Holdings Limited | -15.35 Million HKD | 3333.343% |
| Qianhai Health Holdings Limited | -52.7 Million HKD | 1042.059% |
| Lee's Pharmaceutical Holdings Limited | 16.69 Million HKD | -2873.483% |
| Essex Bio-Technology Limited | 275.25 Million HKD | -80.38% |
| Tongfang Kontafarma Holdings Limited | -28.84 Million HKD | 1821.431% |
| PuraPharm Corporation Limited | -106.08 Million HKD | 568.05% |
| SSY Group Limited | 1.31 Billion HKD | 62.346% |
| JBM (Healthcare) Limited | 130.46 Million HKD | -280.577% |
| Jacobson Pharma Corporation Limited | 266.96 Million HKD | -85.982% |
| China Resources Pharmaceutical Group Limited | 3.85 Billion HKD | 87.118% |